Integrated Profiles of Transcriptome and mRNA m6A Modification Reveal the Intestinal Cytotoxicity of Aflatoxin B1 on HCT116 Cells

Genes (Basel). 2022 Dec 27;14(1):79. doi: 10.3390/genes14010079.

Abstract

Aflatoxin B1 (AFB1) is widely prevalent in foods and animal feeds and is one of the most toxic and carcinogenic aflatoxin subtypes. Existing studies have proved that the intestine is targeted by AFB1, and adverse organic effects have been observed. This study aimed to investigate the relationship between AFB1-induced intestinal toxicity and N6-methyladenosine (m6A) RNA methylation, which involves the post-transcriptional regulation of mRNA expression. The transcriptome-wide m6A methylome and transcriptome profiles in human intestinal cells treated with AFB1 are presented. Methylated RNA immunoprecipitation sequencing and mRNA sequencing were carried out to determine the distinctions in m6A methylation and different genes expressed in AFB1-induced intestinal toxicity. The results showed that there were 2289 overlapping genes of the differentially expressed mRNAs and differentially m6A-methylation-modified mRNAs. After enrichment of the signaling pathways and biological processes, these genes participated in the terms of the cell cycle, endoplasmic reticulum, tight junction, and mitophagy. In conclusion, the study demonstrated that AFB1-induced HCT116 injury was related to the disruptions to the levels of m6A methylation modifications of target genes and the abnormal expression of m6A regulators.

Keywords: AFB1; cell cycle; endoplasmic reticulum stress; m6A modification; mitophagy; tight junction; transcriptome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aflatoxin B1* / toxicity
  • Animals
  • HCT116 Cells
  • Humans
  • Intestines
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Transcriptome*

Substances

  • Aflatoxin B1
  • RNA, Messenger

Grants and funding

The work is supported by the National Natural Science Foundation of China (82104520), Natural Science Foundation of Fujian Province (2021J05045), Fujian Medical University High-level Talent Research Startup Funding Project (XRCZX2020014), Open Research Fund of Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education (FMUGIC-202101).